E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/5/2006 in the Prospect News Biotech Daily.

ExonHit produces new map for human genome expression

By Elaine Rigoli

Tampa, Fla., Sept. 5 - ExonHit Therapeutics SA said Tuesday that it has completed a new messenger RNA (transcripts) map coming from human genome expression, due to the discovery of alternative splicing events, key components of transcriptome diversity (set of expressed genes).

The Paris diagnostic discovery company said its new human genome map will allow the scientific community to characterize, rapidly and easily, transcripts expressed from genes of their choice.

From a set of about 22,000 human genes and the most recent sequence databases, ExonHit said its researchers have identified all of the splicing events present in these databases. These scientists then established a probe set configuration for microarrays, patented in the United States and Europe.

Two million probes are thus established, the company noted, to track all specific expression transcripts known to date and to identify new ones.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.